OGXI

Achieve Life Sciences, Inc.

A Pacific Northwest biopharma company focused on helping people quit nicotine, Achieve Life Sciences develops cytisinicline, a smoking-cessation drug derived from the golden chain tree's seeds. The compound traces back to Eastern European and Central Asian use, and during World War II soldiers even smoked the tree's leaves as a tobacco substitute when supplies ran short. The company took its current form in a 2017 merger with OncoGenex, and its name reflects its goal of helping people "achieve" quitting.